| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 147, 1097-1104, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
CM Mooy, GP Luyten, PT de Jong, TM Luider, T Stijnen, F van de Ham, CC van Vroonhoven and FT Bosman
Department of Pathology, Erasmus University, Rotterdam, The Netherlands.
Neoplasia can be defined as deregulated tissue homeostasis caused by an imbalance between proliferation and apoptosis. Many genes are involved in the maintenance of tissue homeostasis, eg, the c-myc oncoprotein, which is an important regulator of cell proliferation and Bcl-2 protein, which is involved in the regulation of apoptosis. We studied retrospectively indices of proliferation, such as mitotic count and the Mib-1 index, on 51 uveal melanomas and compared their prognostic significance with established indicators of prognosis such as cell type and tumor size. Along the same line we investigated the expression of the regulating proteins c-myc and Bcl-2. Of all parameters tested, the largest tumor diameter and mitotic count were most strongly associated with tumor-related death (P < 0.001 and P = 0.005, respectively). In addition, cell type, the presence of epithelioid cells, the Mib-1 index, and the percentage of cytoplasmic c-myc-positive cells were significant predictive factors. Multivariate analysis showed that the Mib-1 index, largest tumor diameter, and the percentage of cytoplasmic c-myc-positive cells were independent prognostic parameters. Bcl-2 expression did not correlate with clinical outcome. The Mib-1 index correlated with the presence of epithelioid cells (P < 0.03) and the presence of apoptotic bodies (P < 0.001) and c-myc. A strong inverse relationship was found between (nuclear and cytoplasmic) c-myc and Bcl- 2 (P < 0.00004 and P < 0.006, respectively), suggesting that Bcl-2 cooperates with c-myc to immortalize uveal melanoma cells.
This article has been cited by other articles:
 |
|
 |
|
  R. D. Braun and A. Abbas Orthotopic Human Choroidal Melanoma Xenografts in Nude Rats with Aggressive and Nonaggressive PAS Staining Patterns Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 7 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Klisovic, S. E. Katz, D. Effron, M. I. Klisovic, J. Wickham, M. R. Parthun, M. Guimond, and G. Marcucci Depsipeptide (FR901228) Inhibits Proliferation and Induces Apoptosis in Primary and Metastatic Human Uveal Melanoma Cell Lines Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2390 - 2398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Parrella, O. L. Caballero, D. Sidransky, and S. L. Merbs Detection of c-myc Amplification in Uveal Melanoma by Fluorescent In Situ Hybridization Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1679 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chiquet, J.-D. Grange, L. Ayzac, P. Chauvel, L.-M. Patricot, and M. Devouassoux-Shisheboran Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas Br. J. Ophthalmol., January 1, 2000; 84(1): 98 - 102. [Abstract] [Full Text]
|
|
|
|
|
|
J S Chana, G D Wilson, I A Cree, R A Alexander, N Myatt, M Neale, A J E Foss, and J L Hungerford c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma Br. J. Ophthalmol., January 1, 1999; 83(1): 110 - 114. [Abstract] [Full Text]
|
|
|
|
|
|
S E Coupland, N Bechrakis, A Schüler, I Anagnostopoulos, M Hummel, N Bornfeld, and H Stein Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma Br. J. Ophthalmol., August 1, 1998; 82(8): 961 - 970. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
